The presence or absence of lymph node metastases has been claimed as the single most
important prognostic factor in breast cancer, what may not hold true for the smallest tumors …

Axillary node status is a major prognostic factor in early‐stage disease. Traditional staging
needs levels I and II axillary lymph node dissection. Axillary involvement is found in 10 …

Axillary nodal status assessed by traditional histological methods is a proven independent
prognostic factor in breast cancer. Sentinel lymph node biopsy is a surgical pathologic …

Since Morton's pioneering report in 1992, 1 sentinel lymph node (SLN) biopsy has entered
medical practice with astonishing rapidity, and has largely replaced axillary dissection …

Recent data indicates that the sentinel lymph node biopsy (SLNB) is a possible alternative to
axillary lymph node dissection (ALND) in early breast cancer patients, with minimal risk of …

The most powerful predictor of survival in breast cancer is the presence or absence of lymph
node metastases. Lymphatic mapping and sentinel node biopsy is a new technique that …

Abstract Background and Methods Sentinel lymph node (SLN) biopsy is a useful way of
assessing axillary nodal status in breast cancer patients. Recently, several surgeons have …

Sentinel lymph node biopsy (SLNB) has evolved as a safe alternative for staging of the axilla
in patients with clinically node-negative breast cancer. The sentinel node is most often …

No one will deny that the existence of lymph node metastasis from invasive breast
carcinoma will impact upon the management of the patient as metastasis is associated with …

Sentinel lymph node (SN) biopsy has become increasingly used for the staging of breast
carcinoma, resulting in the upstaging of this disease, and this has led to concerns with …